5 High Growth NASDAQ Stocks to Buy Now

3. Neurocrine Biosciences Inc. (NASDAQ:NBIX)

Number of Hedge Fund Holders: 53

Neurocrine Biosciences Inc. (NASDAQ:NBIX) is one of the high growth NASDAQ stocks to buy now. On June 15, Neurocrine Biosciences presented two-year Phase 3 data at ENDO 2026 showing that CRENESSITY (crinecerfont) improves growth outcomes in pediatric patients with classic congenital adrenal hyperplasia. Patients with advanced bone age at baseline experienced slowed progression and significant improvements in predicted adult height, attributed to sustained androgen control and reduced glucocorticoid exposure.

Caregiver feedback further highlights the positive impact of the treatment. Every caregiver surveyed reported overall satisfaction and a willingness to recommend the therapy, while noting increased optimism regarding their child’s future health and a reduction in concerns related to long-term steroid use.

CRENESSITY remained well-tolerated throughout the two-year study with no new safety signals. Beyond improved skeletal maturation, these findings build on previous evidence that the treatment supports better cardiometabolic health by enabling a substantial reduction in glucocorticoid dosing.

Neurocrine Biosciences Inc. (NASDAQ:NBIX) is a biopharmaceutical company with a focus on neuroscience. It is involved in the R&D, sale, and commercialization of pharmaceuticals that treat neuroendocrine, neurological, and neuropsychiatric disorders.

1281292 - 11759070 - 1